Gregory Cole Davis, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 15,000 shares at $2.00 ($30K) on 2019-05-31, disclosed to the SEC on 2019-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.99 | 5,000 | $10K | 33.4% |
| 2 | $1.96 | 5,000 | $10K | 32.9% |
| 3 | $2.00 | 5,000 | $10K | 33.6% |
| Total | $1.98 avg | 15,000 | $30K | 100% |
| Filing → |